<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=213807269037206&amp;ev=PageView&amp;noscript=1">

2016 FDA Warning Letters

TOP 5 Reasons AN FDA WARNING LETTER IS ISSUED TO AN IRB

At IMARC Research, we review the warning letters issued to Clinical Investigators on a yearly basis and recently put together a whitepaper on the 2016 findings. This year, we also reviewed the warning letters issued to IRBs, with the intention of understanding the expectations of IRBs set forth by the FDA.

 

Please fill out the form to the right to get the guide.

IRB_Warning_Letters_Thumbnail.png

Download Today!